Results 181 to 190 of about 7,482 (199)

Sugammadex

Reactions Weekly, 2019
openaire   +2 more sources

Sugammadex

Reactions Weekly, 2014
openaire   +1 more source

Unrestricted Access to Sugammadex: Impact on Neuromuscular Blocking Agent Choice, Reversal Practice and Associated Healthcare Costs

Anaesthesia and Intensive Care, 2012
Thomas Ledowski
exaly  

Short‐term safety and effectiveness of sugammadex for surgical patients with end‐stage renal disease: a two‐centre retrospective study

Anaesthesia, 2020
exaly  

Safety of sugammadex for reversal of neuromuscular block

Expert Opinion on Drug Safety, 2019
Christian Martini, Monique van Velzen, Albert Dahan   +2 more
exaly  

Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study

British Journal of Anaesthesia, 2015
exaly  

Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment

British Journal of Anaesthesia, 2012
exaly  

Sugammadex in the management of rocuronium-induced anaphylaxis

British Journal of Anaesthesia, 2011
exaly  

Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy non-anaesthetised volunteers

British Journal of Anaesthesia, 2018
exaly  

Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20) ,

British Journal of Anaesthesia, 2016
Manfred Blobner, Stefan J Schaller
exaly